Explore the Global Osteoarthritis Gene Therapy Market — Analysis of Key Trends, Regional Growth, Top Players, and a 10-Year Forecast from 2026 to 2036

Future Market Insights

Osteoarthritis Gene Therapy Market

Key Insight

FMI notes osteoarthritis gene therapy market surpassed a value of USD 8.7 billion in 2025. Demand is expected to reach USD 9.4 billion in 2026 and USD 20.1 billion by 2036. In vivo gene therapy is anticipated to lead by Therapy Type with 52.8% share in 2026, at a CAGR of 7.9% and Viral vectors is estimated to lead by Vector Type in 2026.

April 16, 2026

Anurag Sharma

290 Pages

Cite this Report

Osteoarthritis Gene Therapy Market

https://www.futuremarketinsights.com/reports/osteoarthritis-gene-therapy-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Belief BioMed
Genascence
Kolon Tissue Gene
Pacira BioSciences
Xalud Therapeutics

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Osteoarthritis Gene Therapy Market

Key Players

Similar Industry Reports